Submitted by Diane Farsetta on
According to internal documents, the pharmaceutical company Wyeth "paid ghostwriters to produce medical journal articles favorable to its female hormone replacement therapy Prempro." As early as 1997, Wyeth paid the "medical writing firm" DesignWrite to publish favorable journal articles about Prempro under academics' names.
Submitted by Sheldon Rampton on
The Canadian Association of University Teachers has strongly condemned a new lawsuit by the Apotex pharmaceutical company against Dr. Nancy Olivieri. As a liver specialist at the University of Toronto, Olivieri first came under attack from Apotex in 1996 when she notified her patients that she had detected toxic side effects while conducting an Apotex-sponsored study of the company's drug, deferiphone.
Submitted by Sheldon Rampton on
Doctors Frederick Goodwin and Joseph Biederman are counterattacking in an effort to defend their reputations following disclosures that they took millions of do
Submitted by Bob Burton on
As scientific warnings about the potential risks of climate change intensify, governments realize they need to at least be seen as responsive to global warming concerns. But, behind the scenes, many of the world's richest countries are dragging their feet.
Submitted by Sheldon Rampton on
CNN has announced that it will cut its entire science, technology, and environment news staff, a move that Christy George of the Society of Environmental Journalists called "disheartening." Other networks have also been slashing science and environmental jobs, including NBC Universal's The Weather C
Submitted by Sheldon Rampton on
Biopure, a company that makes blood substitutes, is suing scientist Charles Natanson for defamation after he published a critical review in the Journal of the American Medical Association. Nature magazine has condemned the lawsuit.
Submitted by Sheldon Rampton on
Science reporting "is more and more the direct product of PR shops," according to Charles Petit, a veteran science reporter who runs MIT’s online Knight Science Journalism Tracker.
Submitted by Anne Landman on
Submitted by Bob Burton on
A cardinal rule amongst statisticians is to avoid comparing apples with oranges. But it seems that Danish statistician and climate change skeptic Bjorn Lomborg has no such reservations.
Submitted by Diane Farsetta on
The same month that Martin Philbert was named the chair of a U.S. Food and Drug Administration (FDA) panel considering the safety of bisphenol A, a defender of the chemical made a $5 million grant to Philbert's research center.
Center for Media and Democracy
P.O. Box 259010 • Madison, WI 53725 • (608) 260-9713
© 1993-2016
A three-year, $7 million neuromarketing study done in Oxford, England has found that cigarette health warning labels actually make